CARDIFF ONCOLOGY, INC. Employee-related Liabilities, Current
CARDIFF ONCOLOGY, INC. (CRDF) had Employee-related Liabilities, Current of $3.26 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:EmployeeRelatedLiabilitiesCurrent · last filed 2026-08-11
- 2026-06-30: Employee-related Liabilities, Current $3.26M.
- 2026-03-31: Employee-related Liabilities, Current $4.53M.
- 2025-12-31: Employee-related Liabilities, Current $2.43M.
- 2025-09-30: Employee-related Liabilities, Current $3.14M.
| Period end | Employee-related Liabilities, Current | Employee-related Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.26M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $4.53M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $2.43M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $3.14M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $2.25M 10-Q · filed 2025-07-29 | |
| 2025-03-31 | $1.30M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $2.75M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $1.99M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.79M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $1.23M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $2.74M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $2.46M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $2.17M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $983.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $1.85M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $1.61M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $1.30M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $878.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $1.44M 10-K · filed 2023-03-02 | |
| 2020-12-31 | $1.52M 10-K · filed 2022-02-24 | $1.52M 10-K · filed 2021-02-25 |
| 2019-12-31 | $1.00M 10-K · filed 2021-02-25 | |
| 2018-12-31 | $780.85K 10-K · filed 2020-02-27 | |
| 2017-12-31 | $618.13K 10-K · filed 2019-03-06 | |
| 2016-12-31 | $2.20M 10-K · filed 2018-02-26 | |
| 2015-12-31 | $896.40K 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |